Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 481-486

  Molnar J ^a   Hever A ^a   Fakla, I ^a   Fischer, J ^a   Ocsovski, I ^a   Aszalos A ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Brain capillaries; Cancer; mdr; P glycoprotein in bacteria; Phenothiazines

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CHLORPROMAZINE; CHLORPROMAZINE DERIVATIVE; GLYCOPROTEIN P; HEMOLYSIN; LECTIN; MEMBRANE PROTEIN; PHENOTHIAZINE DERIVATIVE; RHODAMINE; TETRACYCLINE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CANCER CELL CULTURE; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG PROTEIN BINDING; DRUG RETENTION; ESCHERICHIA COLI; LYMPHOMA CELL; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN TRANSPORT; TOMATO;

ANIMALS; BLOOD-BRAIN BARRIER; CARRIER PROTEINS; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; HEMOLYSIN PROTEINS; MICE; P-GLYCOPROTEIN; PHENOTHIAZINES; PLASMIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0031057694     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Oucllette M, Legare D, Papadopoulou B: Microbial multidrug resistance ABC transporters. Trends in Microbiol 2: 407-410, 1994.
2. Jacoby G: Extrachromosomal resistance in Gram negative organisms: the evolution of betulactamase. Trends in Microbiol 2: 357-36, 1994.
3. Van Jen Bossche H, Marichal P, Odds FC: Moloeuler mechanisms of drug resistance in fungi. Trends in Microbiol 2: 393-401, 1994.
4. Richman DD: Drug resistance in viruses, Trends in Microbiol 2: 401-406, 1994.
5. Molnár J, Király J, Mandi Y: The antibacterial action and R-factor inhibiting activity by chlorpromazine. Experientia 31: 444-445, 1975.
6. Gerlach JH, Endicott JA, Juranka PF, Henderson G, Sarangi F, Deuchars KL, Victor Ling: Homolog between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324: 485-489, 1986.
7. Molnár J, Földeák S, Nakamura MJ, Rausch H, Domonkos K, Szabó M: Antiplasmid activity: loss of bacterial resistance to antibiotics. Acta Path. Microbiol Immunol Scand 30: 24-31, 1992.
8. Tsuruo T: Biochemical function of p-glycoprotein and implication for therapy. In: The Mechanism and now Approach of Drug Resistance of Cancer Cells Eds Miynzaki T, Takaku F, Sakurada, Elsevier, p 81-91, 1993.
9. Jetté L, Fouliot JF, Murphy GF, Beliveau R: Isoform I (mdr 3) is the major form of p-glycoprotein expressed in mouse brain capillaries. Biochem J 305: 761-766, 1995.
10. Molnár J, Mándi Y, Hevér A, Ocsovszky I, Földeák S, Sncider J, Emódy L, Aszalós A: Reversal of drug resistance in bacteria and tumor cells by some substituted phenothiazines. Anticancer Res 15/5 A, 1648, 1995.
11. Fakla I, Fischer J et al: Manuscript in preparation 1996.
12. Ishikawa M, Yoshimura A, Furakawa T, Sumizawa T, Nakazima Y, Shinichi A : Glycosylation of p-glycoprotein in a multidrug resistant KB cell line and in the human tissues. Biochim Biophys Acta 1073: 309-315, 1991.
13. Hewlett J, Lee S, Molnár J, Földeák S, Pine PS, Weaver JL, Aszalós A: Inhibition of HIV infection of H9 cells by chlorpromazine derivatives. AIDS and Anti-Retroviral Res (to be published).
14. Cornwell MM, Pastan I, Gottesman MM: Certain calcium channel blockers bind specifically to multidrug resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoproiein. J Biol Chem 262: 2166-2170, 1987.
15. Alföldi L, Raskó I, Kerekes E: L-serine deaminase of E. coli. J Bacteriol 96: 1512-1518, 1968.
16. Mándi Y, Molnár J: Effects of chlorpromazine on conjugal plasmid transfer and sex pili. Acta Microbiol Acad Sci Hung 28: 205-210, 1981.
17. Lederberg J, Lederberg EM: Replica plating und indirect selection of bacterial mutants. J Bact 63: 399-406. 1952.
18. Dallaire, L, Tremblay L, Beliveau: Purification and characterization of mefabolically active capillaries of the bloodbrain barrier. Biochem J 276: 745-752, 199
19. Molnár J, Haszon I, Bodrogi T, Martonyi E, Túri S: Synergistic effect of promethazine with gentamycin in frequently recurring pyelonephritis. Int J Urol Nephrol 22: 405-411, 1990.
20. Molnár J, Pusztai R, Hevér A, Nagy Sz, Motohashi N: Effects of two benzo(a)phenothiazines on multidrug resistance (mdr) and tumor antigen expression. Anticancer Res 25: 2013-2016, 1995.
21. Molnar J, Mándi Y, Boda K, Földeák S: The effect of ring-substituted and quaternary chlorpromazine derivatives on the survival time of the NK/Ly ascites tumor bearing mice. Neoplasma 29: 215-222 1982.
22. Mulnár J, Taródi B, Gálfi M, Matkovics B, Motohashi N: In vitro antiprolifiirative effects of tricyclic psychopharmaceutical agents and synergism with some resistance modifiers. Anticancer Res 12: 273-280, 1992.